Dexcom® Introduces Apps That Enable the First Ever Continuous Glucose Monitoring (CGM) on the Apple Watch™

Now People With Diabetes and Caregivers Have Access to Life-Saving Glucose Data in a Convenient and Discreet Manner Right from their Wrist

SAN DIEGO(BUSINESS WIRE)Dexcom, Inc., (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that its Dexcom G4 PLATINUM Continuous Glucose Monitor System with Share will support the Apple Watch when it ships to customers onApril 24. As the industrys first mobile-connected system, Dexcom CGM and its mobile apps, Share2 and Follow, are already approved by theFDAand allow both users and followers to view glucose data directly on their iPhone. The Apple Watch apps fromDexcomwill now enable users to monitor glucose on the Apple Watch so that people with diabetes can discreetly view their own information while parents and caregivers can conveniently view a child or loved ones glucose data, giving them peace of mind and reassurance when they are apart.

Dexcom CGM provides patients the opportunity to track their glucose levels and trends right on their wrist with the Apple Watch. Additionally, patients or Sharers can invite up to five people to view their glucose information and send an alert when the sharers glucose levels are outside the norm.

Dexcom is committed to providing our patients with access to the most current technology to better manage their diabetes, statedKevin Sayer, Chief Executive Office ofDexcom. We are excited that the Dexcom CGM glucose data is now available on the Apple Watch, allowing greater convenience for those who want this important information in an easy-to-use and discreet form. We share Apples commitment to making technology more accessible, relevant and personal.